News
Improvement by ten orders of magnitude
A press release from our partner company reports that our newest generation of cancer-fighting drugs is ten billion times more potent than TLD-1433, the drug currently being studied in a human trial.
A press release from our partner company reports that our newest generation of cancer-fighting drugs is ten billion times more potent than TLD-1433, the drug currently being studied in a human trial.
